Page last updated: 2024-08-24

tenofovir and 1-anilino-8-naphthalenesulfonate

tenofovir has been researched along with 1-anilino-8-naphthalenesulfonate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Buti, M; Crans, G; Flaherty, J; Flisiak, R; Gaggar, A; Gane, E; Janssen, HLA; Jump, B; Kaita, K; Kitrinos, K; Manns, M; Marcellin, P; Op den Brouw, M; Wong, DK1
Cattaneo, D; Filice, C; Gervasoni, C; Riva, A1

Trials

1 trial(s) available for tenofovir and 1-anilino-8-naphthalenesulfonate

ArticleYear
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.
    The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:4

    Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipase; Liver; Male; Middle Aged; Nucleotides; Reverse Transcriptase Inhibitors; Symptom Flare Up; Tenofovir; Withholding Treatment

2019

Other Studies

1 other study(ies) available for tenofovir and 1-anilino-8-naphthalenesulfonate

ArticleYear
Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report.
    International journal of STD & AIDS, 2020, Volume: 31, Issue:10

    Topics: Acute Disease; Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Lipase; Male; Pancreas; Pancreatitis; Piperazines; Pyridones; Tenofovir; Ultrasonography

2020